CD274 and stroke disorder: This suggests the application potential of a novel therapy using accessible humanized anti-PD-L1 antibodies to treat human stroke subjects and confirms that PD-1 is inversely correlated with the absolute amount of CD4+ T central memory (TCM) cells in ischaemic patients [135].